Tolosa ES - Search Results

1

α-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson's disease.

Garrido A, Fairfoul G, Tolosa ES, Martí MJ, Green A; Barcelona LRRK2 Study Group. Garrido A, et al. Among authors: tolosa es. Ann Clin Transl Neurol. 2019 May 9;6(6):1024-1032. doi: 10.1002/acn3.772. eCollection 2019 Jun. Ann Clin Transl Neurol. 2019. PMID: 31211166 Free PMC article.

2

New and emerging strategies for improving levodopa treatment.

Tolosa ES, Valldeoriola F, Martí MJ. Tolosa ES, et al. Neurology. 1994 Jul;44(7 Suppl 6):S35-44. Neurology. 1994. PMID: 8047259 Review.

3

Striated anal sphincter denervation in patients with progressive supranuclear palsy.

Valldeoriola F, Valls-Solé J, Tolosa ES, Marti MJ. Valldeoriola F, et al. Among authors: tolosa es. Mov Disord. 1995 Sep;10(5):550-5. doi: 10.1002/mds.870100504. Mov Disord. 1995. PMID: 8552104

4

Treatment with botulinum toxin injections does not change brainstem interneuronal excitability in patients with cervical dystonia.

Valls-Sole J, Tolosa ES, Marti MJ, Allam N. Valls-Sole J, et al. Among authors: tolosa es. Clin Neuropharmacol. 1994 Jun;17(3):229-35. doi: 10.1097/00002826-199406000-00002. Clin Neuropharmacol. 1994. PMID: 9316668 Clinical Trial.

5

The 'geste antagonistique' induces transient modulation of the blink reflex in human patients with blepharospasm.

Gómez-Wong E, Martí MJ, Cossu G, Fabregat N, Tolosa ES, Valls-Solé J. Gómez-Wong E, et al. Among authors: tolosa es. Neurosci Lett. 1998 Jul 24;251(2):125-8. doi: 10.1016/s0304-3940(98)00519-9. Neurosci Lett. 1998. PMID: 9718990

6

Postural and action myoclonus in patients with parkinsonian type multiple system atrophy.

Salazar G, Valls-Solé J, Martí MJ, Chang H, Tolosa ES. Salazar G, et al. Among authors: tolosa es. Mov Disord. 2000 Jan;15(1):77-83. doi: 10.1002/1531-8257(200001)15:1<77::aid-mds1013>3.0.co;2-n. Mov Disord. 2000. PMID: 10634245

7

Further extension of the H1 haplotype associated with progressive supranuclear palsy.

Pastor P, Ezquerra M, Tolosa E, Muñoz E, Martí MJ, Valldeoriola F, Molinuevo JL, Calopa M, Oliva R. Pastor P, et al. Mov Disord. 2002 May;17(3):550-6. doi: 10.1002/mds.10076. Mov Disord. 2002. PMID: 12112206

8

Dementia in Parkinson disease: a proton magnetic resonance spectroscopy study.

Summerfield C, Gómez-Ansón B, Tolosa E, Mercader JM, Martí MJ, Pastor P, Junqué C. Summerfield C, et al. Arch Neurol. 2002 Sep;59(9):1415-20. doi: 10.1001/archneur.59.9.1415. Arch Neurol. 2002. PMID: 12223027

9

Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity.

Saura J, Parés M, Bové J, Pezzi S, Alberch J, Marin C, Tolosa E, Martí MJ. Saura J, et al. J Neurochem. 2003 May;85(3):651-61. doi: 10.1046/j.1471-4159.2003.01676.x. J Neurochem. 2003. PMID: 12694391 Free article.

10

Clinical overview of the synucleinopathies.

Martí MJ, Tolosa E, Campdelacreu J. Martí MJ, et al. Mov Disord. 2003 Sep;18 Suppl 6:S21-7. doi: 10.1002/mds.10559. Mov Disord. 2003. PMID: 14502652 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters